Trial · NCT01347580
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Thrombolysis In Myocardial Infarction (TIMI) Flow Grade 3 of MI Culprit Vessel at Initial Angiography (Co-primary Endpoint) | At initial angiography, pre PCI | mITT, on patients with non missing values | patients | NUMBER |
| PRIMARY | ST-segment Elevation Resolution Pre PCI ≥70% (Co-primary Endpoint) | Between baseline and PCI | mITT, on patients with non missing values | patients | NUMBER |
| SECONDARY | 1st Composite Clinical Endpoint | during the 30 days of treatment | mITT | patients | NUMBER |
| SECONDARY | 2nd Composite Clinical Endpoint | within 30 days of study | mITT | patients | NUMBER |
| SECONDARY | Definite Stent Thrombosis | during 30 days of treatment | mITT | patients | NUMBER |
| SECONDARY | TIMI Flow Grade 3 Post -PCI | at coroangiography post-PCI | mITT, on patients with non missing TIMI flow grade values | patients | NUMBER |
| SECONDARY | ST Segment Elevation Resolution Post-PCI >= 70% | Between baseline and ECG 60 mn post-PCI | mITT on patients with non missing ECG values | patients | NUMBER |
| SECONDARY | Thrombotic Bail-out With GPIIb/IIIa Inhibitors at Initial PCI | during PCI | mITT | patients | NUMBER |
| SECONDARY | Major Bleeds Within 48 Hours | within 48 hours of first dose | Safety | patients | NUMBER |
| SECONDARY | Minor and Major Bleedings Within 48 Hours | within 48 hours of first dose | Safety | patients | NUMBER |
| SECONDARY | Major Bleeds After 48 Hours | after 48hours post-first dose | safety | patients | NUMBER |
| SECONDARY | Minor and Major Bleeds After 48 Hours | after 48 hours post first dose | safety | patients | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01347580/outcomes